Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | KIT |
Variant | C443Y |
Impact List | missense |
Protein Effect | gain of function - predicted |
Gene Variant Descriptions | KIT C443Y lies within Ig-like C2-type domain 5 of the Kit protein (UniProt.org). C443Y results in constitutive ligand-independent activation of Kit in cell culture (PMID: 19865100), and therefore, is predicted to lead to a gain of Kit protein function. |
Associated Drug Resistance | |
Category Variants Paths |
KIT mutant KIT act mut KIT C443Y KIT mutant KIT exon8 KIT C443Y |
Transcript | NM_000222.3 |
gDNA | chr4:g.54723680G>A |
cDNA | c.1328G>A |
Protein | p.C443Y |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001093772.1 | chr4:g.54723680G>A | c.1328G>A | p.C443Y | RefSeq | GRCh38/hg38 |
NM_000222.3 | chr4:g.54723680G>A | c.1328G>A | p.C443Y | RefSeq | GRCh38/hg38 |
XM_017008178.1 | chr4:g.54723680G>A | c.1328G>A | p.C443Y | RefSeq | GRCh38/hg38 |
NM_000222.2 | chr4:g.54723680G>A | c.1328G>A | p.C443Y | RefSeq | GRCh38/hg38 |
NM_001093772.2 | chr4:g.54723680G>A | c.1328G>A | p.C443Y | RefSeq | GRCh38/hg38 |
NM_001093772 | chr4:g.54723680G>A | c.1328G>A | p.C443Y | RefSeq | GRCh38/hg38 |
NM_000222 | chr4:g.54723680G>A | c.1328G>A | p.C443Y | RefSeq | GRCh38/hg38 |
XM_017008178 | chr4:g.54723680G>A | c.1328G>A | p.C443Y | RefSeq | GRCh38/hg38 |
NM_001385285.1 | chr4:g.54723680G>A | c.1328G>A | p.C443Y | RefSeq | GRCh38/hg38 |
NM_001385286.1 | chr4:g.54723680G>A | c.1328G>A | p.C443Y | RefSeq | GRCh38/hg38 |
XM_017008180.1 | chr4:g.54723680G>A | c.1328G>A | p.C443Y | RefSeq | GRCh38/hg38 |
XM_017008180 | chr4:g.54723680G>A | c.1328G>A | p.C443Y | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|